Search Results - "Hacker, Kari"

Molecular testing for endometrial cancer: An SGO clinical practice statement by Walsh, Christine S., Hacker, Kari E., Secord, Angeles Alvarez, DeLair, Deborah F., McCourt, Carolyn, Urban, Renata

“…The Cancer Genome Atlas publication first described the genomic landscape of endometrial cancer and characterized these cancers into four molecular subtypes…”
Get full text

Ongoing strategies and updates on pain management in gynecologic oncology patients by Hacker, Kari E., Reynolds, R. Kevin, Uppal, Shitanshu

“…The opioid crisis in the United States has been declared a public health emergency. Various governmental agencies, cancer care organizations and the Centers…”
Get full text

Race- associated molecular differences in uterine serous carcinoma by Lara, Olivia D, Karpel, Hannah, Friedman, Steven, Hacker, Kari E, Pothuri, Bhavana

“…Endometrial cancer (EMCA) is the most common gynecologic malignancy, and new diagnoses are increasing in the United States. Black patients are more likely to…”
Get full text

SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma by Lara, Olivia D., Van Oudenhove, Elke, Pereira, Luiza, Misirlioglu, Selim, Levine, Douglas A., Hacker, Kari E.

“…•Unveiling new treatment strategies in tubo-ovarian carcinoma (TOC) remains a high unmet need.•The small molecular inhibitor, SPL-108, has anti-metastatic…”
Get full text

Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization by Messer, William B, Yount, Boyd, Hacker, Kari E, Donaldson, Eric F, Huynh, Jeremy P, de Silva, Aravinda M, Baric, Ralph S

“…Dengue viruses (DENV) are enveloped single-stranded positive-sense RNA viruses transmitted by Aedes spp. mosquitoes. There are four genetically distinct…”
Get full text

Disseminated Actinomyces Case Report: A Mimicker of Advanced Ovarian Malignancy by D'Iorio, Maria, Lara, Olivia D, Hacker, Kari E

“…Disseminated actinomyces is a rare infection that presents with subtle symptoms and radiographic findings. Patients frequently complain of pelvic pain and…”
Get full text

Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer by Hacker, Kari E, Uppal, Shitanshu, Johnston, Carolyn

“…Borderline ovarian tumors (BOTs) are less common than epithelial ovarian cancers (EOCs). Low-grade EOCs (LG-EOCs) occur even less frequently than BOTs. After…”
Get more information

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival by Hacker, Kari E, Bolland, Danielle E, Tan, Lijun, Saha, Anjan K, Niknafs, Yashar S, Markovitz, David M, McLean, Karen

“…DNA damage repair alterations play a critical role in ovarian cancer tumorigenesis. Mechanistic drivers of the DNA damage response consequently present…”
Get full text

Ninety-Day Mortality as a Reporting Parameter for High-Grade Serous Ovarian Cancer Cytoreduction Surgery by Spencer, Ryan J., Hacker, Kari E., Griggs, Jennifer J., Rice, Laurel W., Reynolds, R. Kevin, Uppal, Shitanshu

“…OBJECTIVE:To evaluate the utility of using 90-day as an adjunct to 30-day mortality rates after surgical cytoreduction for serous ovarian cancer and to compare…”
Get full text

The Twin-Arginine Translocation Pathway of Mycobacterium smegmatis Is Functional and Required for the Export of Mycobacterial β-Lactamases by MCDONOUGH, Justin A, HACKER, Kari E, FLORES, Anthony R, PAVELKA, Martin S, BRAUNSTEIN, Miriam

“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

HER2-low and HER2+ endometrial cancers in a cohort of patients with P53 aberrant expression (1318) by Hacker, Kari, Pothuri, Bhavana

Get full text

HER2 status, MMR, and p53 expression among endometrial cancer patients by Allen, Kathryn, Hacker, Kari, Lee, Sarah, Pothuri, Bhavana

Get full text

HER2 status among a cohort of endometrial cancer patients by Hacker, Kari, Allen, Kathryn, Lee, Sarah, Pothuri, Bhavana

Get full text

A molecular perspective: Racial disparities in uterine serous carcinoma (085) by Lara, Olivia, Karpel, Hannah, Fehniger, Julia, Hacker, Kari, Pothuri, Bhavana

Get full text

Molecular characteristics of advanced/recurrent endometrial cancer patients with non-specific molecular profile (1302) by Lee, Sarah, Allen, Kathryn, Espino, Kevin, Karpel, Hannah, Hacker, Kari, Pothuri, Bhavana

Get full text

Simultaneous HER2 positivity and CCNE1 amplification is associated with Black race and worsened overall survival in endometrial cancer (185) by Lee, Sarah, Allen, Kathryn, Espino, Kevin, Karpel, Hannah, Hacker, Kari, Lightfoot, Michelle, Pothuri, Bhavana, Growdon, Whitfield

Get full text

Next-generation sequencing complements conventional clinical HER2 testing for advanced or recurrent endometrial tumors (183) by Lee, Sarah, Allen, Kathryn, Espino, Kevin, Karpel, Hannah, Growdon, Whitfield, Hacker, Kari, Pothuri, Bhavana

Get full text

PARP and ABCB1 (MDR1) inhibitor treatment of ovarian cancer cell lines and PDX models demonstrate no synergistic effect (244) by Tunnage, Irina, Lara, Olivia, Misirlioglu, Selim, Pereira, Luiza Doro, Abdelrahman, Suhaib, Levine, Douglas, Hacker, Kari

Get full text

SPL-108 mediates metastasis and chemoresistance in high-grade serous tubo-ovarian carcinoma by Lara, Olivia, Pereira, Luiza Doro, Van Oudenhove, Elke, Olvera, Narciso, Dao, Fanny, Hacker, Kari, Levine, Douglas

“…Overcoming chemoresistance will improve outcomes for all women with tubo-ovarian carcinomas. Mechanisms of chemoresistance are multifactorial and…”
Get full text

Treating through the surge: institutional experience of definitive management of cervical cancer patients at an urban institution during the COVID-19 pandemic by Lee, Sarah, Boyd, Leslie, Hacker, Kari, Salame, Ghadir, Pothuri, Bhavana, Schiff, Peter B. Schiff, Lymberis, Stella

“…An international consensus panel has defined locally advanced cervical cancers as a high priority malignancy during the COVID-19 pandemic and recommends prompt…”
Get full text